CSI Market
Sign In | Register

Sage Therapeutics Inc (SAGE) Annual Balance Sheets

Annual · GAAP · USD millions
Access SAGE quarterly Balance Sheets →
Quarterly balance sheet trends provide context on Sage Therapeutics Inc's liquidity, leverage, and long-term financial structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
(Dec 31 2023) (Dec 31 2022) (Dec 31 2021) (Dec 31 2020)
Assets
Cash & cash equivalent81.02
Restricted Cash and Cash Equivalents, Current0.00
Marketable Securities, Current SH423.40
Cash & Short-term Investments504.00
Accounts receivable9.13
Other Receivables, Net, Current0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current17.75
Total Current Assets531.30
Equipment/Property/Plant Net0.89
Long-term investments1.45
Other Assets, Noncurrent5.00
Operating Lease Right Of Use Asset10.75
Total Assets547.22
Liabilities
Accounts Payable, Current AC12.70
Accrued Liabilities, Current AC57.60
Other Liabilities, Current1.32
Total Current Liabilities71.62
Total Long-term Debt0.00
Other liabilities, Noncurrent10.52
Operating Lease Liability Current1.32
Operating Lease Liability Noncurrent10.52
Total Liabilities82.13
Stockholders' Equity
Treasury Stock Common Value-0.40
Common Stock Value0.01
Additional Paid In Capital Common Stock3,435.56
Retained Earnings / Accumulated Deficit-2,970.33
Other Equity0.24
Common Stockholder's Equity465.09
Total Stockholder's Equity465.09
Liabilities & Stockholder's Equity547.22
4 historic quarters locked

Sign in to unlock the full Sage Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Sage Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20241231)
  • Filed with the SEC: February 11, 2025
  • Source: sage-20241231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-25-017909

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License